Combining our enriched real-world data platform with advanced analytics, Arcturis delivers real-world evidence and novel healthcare insights in common and rare diseases. We engage with the whole healthcare ecosystem from NHS Trusts, patients, patient advocacy groups, and researchers in both academia and industry to expand the impact of real-world evidence and improve patient outcomes for the future.
Arcturis uses real-world data to support the discovery and development of new medicines. We translate patient pathways into real-world evidence and insights to improve patient outcomes, advance research and inform industry policy.What we do
What We Do
How we advance your research…
Improving patient outcomes
Generating precision real-world data
Developing biomarker-driven analysis
Accelerating clinical development
Delivering real-world evidence and insights.
Want to be part of our journey? Join our team!
Explore our latest resources
Enabling scalable clinical interpretation of machine learning (ML)-based phenotypes using real world data
Parsons - Journal of Medical Artificial Intelligence (amegroups.com)
External Control Arm for Relapsed/Refractory Multiple Myeloma
The randomised clinical trial (RCT) is the gold standard in drug development.
Evidence-based Trial Protocol Optimisation – Themis trial showcase
One of the main causes for high failure rates of clinical trials is the suboptimal definition of patient selection criteria.
Personalised Therapy in Chronic Kidney Disease
Arcturis researchers have developed AI models to forecast poor prognosis in chronic kidney disease (CKD) and uncover clinical markers that signal the need for specialised treatment.